Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report.

Kaitlyn Baldwin Annabelle Wanson Lee-Anne Gilecki Courtney Dalton Evyn M Peters Katelyn C Halpape

Published in: The mental health clinician (2023)

Intranasal ketamine in this case was effective at treating depressive symptoms and suicidal ideation associated with long COVID. This is consistent with available data that demonstrates ketamine's efficacy in reducing inflammatory mediators associated with neuropsychiatric symptoms. Therefore, ketamine may be a potential therapeutic option to treat long COVID and persistent depressive symptoms.

Keyphrases

coronavirus disease
depressive symptoms
sars cov
pain management
social support
sleep quality
respiratory syndrome coronavirus
big data
smoking cessation